NEW YORK (GenomeWeb News) – French high-content screening vendor Fluofarma said recently that it has entered into a multi-year assay development agreement with Roche.

Under the terms of the partnership, Roche and Fluofarma will work together to develop miniaturized cell-based assays using high-throughput flow cytometry and computational models to improve the predictability of hepatotoxicity and safety profiling of compounds in liver cells.

Financial terms of the partnership were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.